Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging

NCT04120766 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
64
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gregory Jicha, MD, PhD

Collaborators